+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Beta Thalassemia Testing Market - Global Forecast 2025-2030- Product Image
Beta Thalassemia Testing Market - Global Forecast 2025-2030- Product Image
Sale

Beta Thalassemia Testing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013877
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Beta Thalassemia Testing Market is evolving rapidly, shaped by emerging technologies, global healthcare shifts, and regulatory dynamics. Senior leaders seeking to optimize diagnostic strategies must track these developments to inform strategic investments and operational planning.

Market Snapshot: Beta Thalassemia Testing Market

The Beta Thalassemia Testing Market grew from USD 478.47 million in 2024 to USD 521.61 million in 2025. It is expected to continue growing at a CAGR of 8.60%, reaching USD 785.06 million by 2030. This growth is driven by expanding genetic screening programs, advances in testing modalities, and shifts in policy environments globally.

Scope & Segmentation: Comprehensive View of Market Coverage

  • Test Types: Carrier screening, diagnostic testing, newborn screening, point-of-care testing, prenatal screening.
  • Technology Platforms: Capillary electrophoresis, CRISPR-based testing, high-performance liquid chromatography, microarray analysis, next-generation sequencing, polymerase chain reaction.
  • End Users: Blood banks, diagnostic centers, home healthcare services, hospitals, specialty clinics.
  • Distribution Channels: E-commerce platforms, hospital purchases, online channels, pharmacy and retail locations.
  • Sample Types: Amniotic fluid, blood sample, dried blood spot.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., Bio-Rad Laboratories Inc., Natera Inc., BGI Genomics Co. Ltd., Sysmex Corporation.

Key Takeaways for Decision-Makers

  • Diagnostics are shifting from traditional biochemical assays toward molecular and multiplexed approaches, increasing detection accuracy and process efficiency.
  • The integration of digital health platforms and artificial intelligence is streamlining laboratory workflows and supporting remote result interpretation for quicker clinical action.
  • Decentralized testing solutions, particularly point-of-care platforms, are enabling broader access to screening in both urban and resource-limited settings.
  • Strategic industry partnerships and acquisitions are expanding access to innovative technologies and supporting end-to-end supply chain resilience.
  • Focus on regulatory clarity and swift approval processes is facilitating market entry for next-generation diagnostics in key regions.
  • Comprehensive carrier and newborn screening initiatives are being prioritized in public health agendas to enhance early intervention outcomes.

Tariff Impact: Navigating US Policy Changes

Recent trade tariff adjustments in the United States have driven up procurement costs for imported diagnostics and critical components, prompting manufacturers to evaluate regional supply chain partnerships and alternative sourcing methods. These policy shifts are accelerating the adoption of localized manufacturing strategies, fostering new collaborations, and supporting cost-optimized operations across the testing landscape.

Methodology & Data Sources

This report employs a mixed-methods research design, combining in-depth interviews with industry experts, structured surveys of diagnostic providers, and analysis of peer-reviewed literature, patent data, and regulatory databases. Competitive insights are supported by review of corporate disclosures, press releases, and product launch information. Triangulation and expert panel review ensure robust, validated conclusions.

Why This Report Matters: Actionable Insights for Strategic Advantage

  • Gain a 360-degree understanding of evolving beta thalassemia diagnostics to inform investments and operational alignment.
  • Identify emerging technologies, policy shifts, and best practices relevant to supply chain optimization and workflow integration.
  • Leverage segmentation and regional insights to prioritize market entry or expansion strategies with minimized risk.

Conclusion

This report provides an authoritative roadmap for navigating the future of beta thalassemia testing. By focusing on innovation, collaboration, and operational agility, industry leaders can drive sustainable market growth and improve patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of cell-free DNA screening for early non-invasive beta thalassemia carrier detection in high-risk pregnancies
5.2. Emergence of CRISPR-based gene editing as a companion diagnostic in clinical trials for beta thalassemia treatment stratification
5.3. Expansion of point-of-care hemoglobin electrophoresis devices in remote regions to facilitate decentralized beta thalassemia screening
5.4. Partnerships between pharmaceutical companies and diagnostic developers to co-develop targeted beta thalassemia molecular assays
5.5. Regulatory approvals of multiplex PCR panels enabling simultaneous screening of beta thalassemia and common hemoglobinopathies in newborns
5.6. Integration of AI-driven data analytics platforms for predictive modeling of beta thalassemia mutation patterns in diverse populations
5.7. Rising demand for genetic counseling services alongside advanced beta thalassemia test offerings in emerging markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Beta Thalassemia Testing Market, by Test Type
8.1. Introduction
8.2. Carrier Screening
8.3. Diagnostic Testing
8.4. Newborn Screening
8.5. Point-Of-Care Testing
8.6. Prenatal Screening
9. Beta Thalassemia Testing Market, by Technology
9.1. Introduction
9.2. Capillary Electrophoresis
9.3. CRISPR-Based Testing
9.4. High-Performance Liquid Chromatography
9.5. Microarray Analysis
9.6. Next-Generation Sequencing
9.7. Polymerase Chain Reaction
10. Beta Thalassemia Testing Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Diagnostic Centers
10.4. Home Healthcare Services
10.5. Hospitals
10.6. Specialty Clinics
11. Beta Thalassemia Testing Market, by Distribution Channel
11.1. Introduction
11.2. E-Commerce Platforms
11.3. Hospital Purchases
11.4. Online Channels
11.5. Pharmacy & Retail
12. Beta Thalassemia Testing Market, by Sample Type
12.1. Introduction
12.2. Amniotic Fluid
12.3. Blood Sample
12.4. Dried Blood Spot
13. Americas Beta Thalassemia Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Beta Thalassemia Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Beta Thalassemia Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Illumina Inc.
16.3.5. QIAGEN N.V.
16.3.6. PerkinElmer Inc.
16.3.7. Bio-Rad Laboratories Inc.
16.3.8. Natera Inc.
16.3.9. BGI Genomics Co. Ltd.
16.3.10. Sysmex Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BETA THALASSEMIA TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BETA THALASSEMIA TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BETA THALASSEMIA TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BETA THALASSEMIA TESTING MARKET: RESEARCHAI
FIGURE 26. BETA THALASSEMIA TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. BETA THALASSEMIA TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. BETA THALASSEMIA TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BETA THALASSEMIA TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY CRISPR-BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY CRISPR-BASED TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HOME HEALTHCARE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HOME HEALTHCARE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY PHARMACY & RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY PHARMACY & RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY AMNIOTIC FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY AMNIOTIC FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BETA THALASSEMIA TESTING MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BETA THALASSEMIA TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 98. CANADA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 160. GERMANY BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 161. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 162. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 163. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 182. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 183. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ITALY BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 191. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 192. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 193. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 200. SPAIN BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 212. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 220. SAUDI ARABIA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 222. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. SOUTH AFRICA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. DENMARK BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 242. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 243. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 250. NETHERLANDS BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 251. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 252. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 253. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 260. QATAR BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 261. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 262. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 263. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. FINLAND BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 280. SWEDEN BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 281. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 282. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 283. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 290. NIGERIA BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 291. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 292. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 293. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 300. EGYPT BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 301. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 302. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 303. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 310. TURKEY BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 311. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 312. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 313. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 314. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 315. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 320. ISRAEL BETA THALASSEMIA TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 321. NORWAY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 322. NORWAY BETA THALASSEMIA TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 323. NORWAY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 324. NORWAY BETA THALASSEMIA TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 325. NORWAY BETA THALASSEMIA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Beta Thalassemia Testing market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • QIAGEN N.V.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Natera Inc.
  • BGI Genomics Co. Ltd.
  • Sysmex Corporation

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 521.61 Million
Forecasted Market Value ( USD ) by 2030 $ 785.06 Million
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Beta Thalassemia Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Beta Thalassemia Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Adult Hemoglobinopathy Testing Market - Global Forecast 2025-2030 - Product Image

Adult Hemoglobinopathy Testing Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Adult Hemoglobinopathy Testing - Global Strategic Business Report - Product Image

Adult Hemoglobinopathy Testing - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Antithrombin Market - Global Forecast 2025-2030 - Product Image

Antithrombin Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From

About the Beta Thalassemia Testing Market

Beta Thalassemia Testing is a diagnostic test used to detect the presence of the genetic disorder beta thalassemia. The test is used to diagnose the condition in individuals who have a family history of the disorder, or who have symptoms that may indicate the presence of the disorder. The test is typically performed using a blood sample, which is analyzed for the presence of abnormal hemoglobin levels. The test can also be used to determine the severity of the disorder, as well as to monitor the effectiveness of treatment. The Beta Thalassemia Testing market is a growing segment of the Diagnostics industry, with a wide range of products and services available to meet the needs of patients and healthcare providers. Companies in the market include Abbott, Bio-Rad, Siemens, Roche, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.